Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Acute Respiratory Failure-II

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Derivation and validation of clinical prediction models for viral etiologies of acute diarrhea in North American children presenting for emergency care.

medRxiv : the preprint server for health sciences·2026

Same author

Health, economic, and equity impact of a COVID-19 mobile vaccine clinic program in US: a cost-effectiveness analysis.

Lancet regional health. Americas·2026

Same author

Intramuscular Immunoglobulin for Measles Postexposure Prophylaxis.

NEJM evidence·2026

Same author

Association between Weather Variables and Viral Gastroenteritis in the United States.

medRxiv : the preprint server for health sciences·2026

Same author

Effectiveness of mobile vaccine clinics on COVID-19 vaccination uptake in the USA: an observational study.

BMJ public health·2026

Same author

Shiga Toxin-Producing Escherichia coli Outbreak in Canadian Daycare Centers.

JAMA network open·2026

Search research articles

Related Experiment Video

Updated: Mar 14, 2026

Experimental Model to Evaluate Resolution of Pneumonia

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

Predicting Severe Pneumonia Outcomes in Children.

Derek J Williams¹, Yuwei Zhu², Carlos G Grijalva³

¹Departments of Pediatrics, derek.williams@vanderbilt.edu.

|October 1, 2016

Summary

Accurate risk models were developed to predict severe pneumonia in children. These tools can help guide clinical decisions and improve patient outcomes for pediatric pneumonia.

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Related Experiment Videos

Last Updated: Mar 14, 2026

Experimental Model to Evaluate Resolution of Pneumonia

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Area of Science:

Pediatric critical care medicine
Epidemiology of infectious diseases
Clinical decision support systems

Background:

Pediatric pneumonia presents with significant morbidity and variable care.
There is a need for tools to accurately stratify risk and guide treatment decisions.
Community-acquired pneumonia hospitalizations in children require better outcome prediction.

Purpose of the Study:

To develop and validate risk models for predicting severe outcomes in pediatric pneumonia.
To identify key predictors of severe pneumonia in children.
To compare the performance of different risk model configurations.

Main Methods:

Prospective cohort study (Etiology of Pneumonia in the Community Study) of 2319 children hospitalized with pneumonia.
Development of three risk models (full, reduced, EHR) using ordinal regression.
Evaluation of 20 potential predictors including patient, laboratory, and radiographic data.

Main Results:

21% of children experienced moderate (14%) or severe (7%) in-hospital outcomes.
All developed models demonstrated accurate risk prediction for severe pneumonia (concordance index 0.78-0.81).
Key predictors included age, vital signs, chest indrawing, and radiologic infiltrate patterns; reduced and EHR models performed comparably to the full model.

Conclusions:

Three validated risk models accurately estimate the risk of severe pneumonia in children.
Implementation of these models has the potential to enhance clinical decision-making.
These tools may lead to improved care and outcomes for pediatric pneumonia patients.